Fungal infectious disease
MONDO:0002041An infection caused by a fungus.
Also known as: Fungi caused disease or disorder, Fungi disease or disorder, Fungi infection, Fungi infectious disease, mycosis, fungal infection, infection, fungal, infections, Fungi
260 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Newer antifungal cream may beat old standard for skin fungus
⭐️ CURE ⭐️ Not yet recruitingThis study tests whether a newer antifungal cream (luliconazole) works better than the standard treatment (ketoconazole) for pityriasis versicolor, a common fungal skin infection that causes light or dark patches. About 86 adults with the infection will use one of the two creams …
Phase: PHASE4 • Sponsor: PAEC General Hospital, Islamabad • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 08:10 UTC
-
Could a common acne drug help beat tough fungal infections?
Disease control Not yet recruitingThis study compares the standard antifungal drug itraconazole alone versus itraconazole combined with isotretinoin (an acne medication) in adults with tinea corporis or cruris (ringworm of the body or groin). The goal is to see if the combination shortens treatment time and impro…
Phase: PHASE4 • Sponsor: Pak Emirates Military Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New foot fungus film shows promise in early trial
Disease control Not yet recruitingThis early-stage trial tests a new topical film called ZYG24004 for athlete's foot (tinea pedis). About 64 adults with the infection will apply the film to their feet once or twice. The main goals are to check safety, how the body processes the drug, and whether it can clear the …
Phase: PHASE1 • Sponsor: Sinomune Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo could shorten histoplasmosis treatment by half
Disease control Not yet recruitingThis study tests if a single high dose of an antifungal drug works better than the standard daily dose for treating moderate to severe histoplasmosis, a serious lung infection. It also compares a newer oral drug to the standard one, and checks if 6 months of treatment is as good …
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Oxygen chamber therapy put to the test for dozens of diseases
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) — breathing pure oxygen in a pressurized chamber — for over 30 conditions, including long COVID, Crohn's disease, frostbite, and multiple sclerosis. Researchers will track 100 patients to see if HBOT improves their quality of …
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for blood cancer patients with tough fungal infections
Disease control Not yet recruitingThis study looks at whether the drug amphotericin B can treat serious fungal infections that break through in people with blood cancers who are already taking antifungal prevention. About 15 adults will receive the drug for 4-6 weeks and be closely monitored. The goal is to see h…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Which antibiotic combo is safer for your kidneys? new trial aims to find out
Disease control Not yet recruitingThis study compares two common antibiotic combinations—vancomycin with piperacillin/tazobactam versus vancomycin with meropenem—to see which is less harmful to the kidneys. About 852 hospitalized adults with serious infections will be randomly assigned to one of the two combos. T…
Phase: PHASE4 • Sponsor: Bassett Healthcare • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for HIV patients: shorter, stronger fungal infection treatment on trial
Disease control Not yet recruitingThis study tests two new ways to treat talaromycosis, a serious fungal infection in people with HIV. It compares a single high dose of a newer antifungal drug (liposomal amphotericin B) against two weeks of the standard drug, and also checks if adding another medicine (flucytosin…
Phase: PHASE3 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cord blood cells engineered to fight deadly mold in first human test
Disease control Not yet recruitingThis early-phase trial tests a new approach for patients with invasive mold infections that are not responding to standard antifungal medicines. Researchers take natural killer (NK) cells from donated umbilical cord blood and genetically modify them to better target the mold. The…
Phase: PHASE1 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for rare brain fungus: experimental drug olorofim tested
Disease control Not yet recruitingThis study tests a drug called olorofim in people recently diagnosed with coccidioidal meningitis, a rare fungal infection of the brain and spinal cord. About 12 participants will take olorofim and be followed for 6 months to see if it is safe and helps control the infection. The…
Phase: PHASE2 • Sponsor: Fariba Donovan • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New gel could beat toenail fungus faster
Disease control Not yet recruitingThis Phase 2 trial tests a new gel (AP4500) containing the antifungal drug terbinafine for mild to moderate toenail fungus. About 200 adults will apply the gel once or twice daily for 48 weeks. Researchers will compare it to a placebo and an existing treatment (Jublia) to see if …
Phase: PHASE2 • Sponsor: Onyx Axiom • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study seeks best backup plan for deadly pneumonia in immunocompromised patients
Disease control Not yet recruitingThis study looks at which second-choice treatment works best for a serious lung infection called PCP when the usual antibiotic cannot be used due to allergies, side effects, or failure. About 416 adults with weakened immune systems (from HIV, transplants, cancer, or other causes)…
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New study aims to treat deadly fungus in patients with liver issues
Disease control Not yet recruitingThis study tests a drug called liposomal amphotericin B in 40 ICU patients who have a severe fungal infection (invasive aspergillosis) and liver problems. The drug is given daily for 2 weeks, followed by 4 weeks of monitoring. The goal is to see if it is safe and effective for th…
Phase: NA • Sponsor: Southeast University, China • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Cream or pill? new study tests best way to treat fungal skin infection
Disease control Not yet recruitingThis study compares two treatments for pityriasis versicolor, a fungal skin infection that causes discolored patches. One group will apply a clotrimazole cream twice daily for two weeks, while the other takes itraconazole pills daily for five days. The trial aims to see which app…
Phase: PHASE1, PHASE2 • Sponsor: Combined Military Hospital Abbottabad • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Shorter steroid course for severe PCP? new trial aims to find out
Disease control Not yet recruitingThis study looks at how long steroids should be given to adults with severe Pneumocystis pneumonia (PCP), a serious lung infection common in people with weakened immune systems. About 416 participants who improve within 10 days will either stop steroids early or continue for 21 d…
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can UV light beat Drug-Resistant ringworm?
Disease control Not yet recruitingThis study tests whether narrow-band ultraviolet B (NB-UVB) light therapy can help people with ringworm infections that don't get better with standard antifungal drugs. The trial will enroll 36 adults who have had at least two relapses in the past six months. Half will receive UV…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New gel could fight fungal eye infections
Disease control Not yet recruitingThis study tests a new gel called IVIEW-1201 for treating fungal keratitis, a serious eye infection. About 60 people will receive either the gel or a control treatment. The goal is to see if the gel can clear the infection and heal the eye. While it aims to cure the infection, on…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New ear cream trial aims to stop itchy fungal infections
Disease control Not yet recruitingThis study tests a cream called terbinafine hydrochloride for treating fungal ear infections (otomycosis). About 50 adults with symptoms like itching, pain, and discharge will have the cream applied in the ear every two days for two weeks. The goal is to see if the cream clears b…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could steroids slash death rates from a rare pneumonia?
Disease control Not yet recruitingThis study tests whether adding corticosteroids (low or moderate dose) to standard care can reduce deaths from severe Pneumocystis pneumonia (PJP) in non-HIV patients in the ICU. PJP has a very high death rate of 60-80% in this group. The trial will compare two steroid doses agai…
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 26, 2026 14:24 UTC
-
Can steroids save lives in severe pneumonia? new trial aims to find out
Disease control Not yet recruitingThis trial tests whether low or moderate doses of the steroid methylprednisolone can reduce deaths in patients with severe community-acquired pneumonia. It will enroll 1500 ICU patients with pneumonia caused by adenovirus or Pneumocystis jirovecii. The study uses an adaptive desi…
Phase: PHASE2, PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 26, 2026 13:09 UTC
-
Fast new swab test could speed up vaginitis diagnosis
Diagnosis Not yet recruitingThis study will test a new diagnostic device called the Nanopath assay, which aims to quickly detect bacteria or yeast causing vaginitis. Up to 1000 women with symptoms like itching or discharge will provide vaginal swab samples, either collected by a clinician or themselves. The…
Sponsor: Nanopath, Inc • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Blood test breakthrough could speed up fungal lung infection diagnosis
Diagnosis Not yet recruitingThis study aims to see if a new blood test (mNGS) can accurately diagnose invasive fungal lung infections in 1,000 people with blood disorders. Participants will provide a blood sample and undergo standard tests, then be followed for 42 days. The goal is to find a faster, more re…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Rapid brain infection test could slash unnecessary antibiotic use
Diagnosis Not yet recruitingThis study looks at whether a quick diagnostic test (BioFire FilmArray) can accurately predict the cause of meningitis or encephalitis in 182 adults. Participants with symptoms like fever, headache, or confusion will have their spinal fluid tested. The goal is to see if the test …
Phase: NA • Sponsor: Federal University of Health Science of Porto Alegre • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Can a lower dose of antibiotics prevent pneumonia just as well after kidney transplant?
Prevention Not yet recruitingThis study tests whether a lower dose of the antibiotic TMP-SMX works as well as the standard dose to prevent a serious lung infection called PJP in people who have just had a kidney transplant. About 1,084 adult first-time kidney transplant recipients will take either a low or s…
Phase: PHASE4 • Sponsor: Anhui Provincial Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Could a common steroid prevent a deadly complication in AIDS patients?
Prevention Not yet recruitingThis study tests whether a short course of the steroid prednisolone can prevent paradoxical immune reconstitution inflammatory syndrome (IRIS) in people with AIDS who have low CD4 counts and are starting HIV treatment. About 131 participants will receive either prednisolone or no…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Herbal supplement cistanche tested for explosive power and recovery in athletes
Symptom relief Not yet recruitingThis study tested whether taking a cistanche supplement for 8 weeks, along with a supervised training program, improves anaerobic exercise performance and recovery in young men. 56 men aged 18-25, either elite or amateur athletes, were randomly assigned to receive cistanche extra…
Phase: NA • Sponsor: Beijing Sport University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New vaginal ovule aims to soothe recurrent infections
Symptom relief Not yet recruitingThis study tests a medical device called Rephegyn vaginal ovules to help treat fungal (candidiasis) and bacterial infections. The device is designed to help heal the vaginal lining and reduce symptoms like discharge, pain, and itching. About 34 adults with recurrent infections wi…
Sponsor: Innate srl • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Buffalo milk probiotic put to the test for young athletes
Symptom relief Not yet recruitingThis study tests whether a probiotic called Lactiplantibacillus plantarum Dad-13, originally from buffalo milk curd, can improve gut health and physical performance in 30 adolescent athletes. Participants will take the probiotic and have their gut bacteria, inflammation markers, …
Phase: NA • Sponsor: Gadjah Mada University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Shorter or longer? study tests best duration for fungal shampoo treatment
Symptom relief Not yet recruitingThis study looks at whether using ketoconazole 2% shampoo for seven days works better than using it for three days to treat pityriasis versicolor, a common fungal skin condition that causes discolored patches. About 76 people aged 12 and older with confirmed infection will be ran…
Phase: PHASE4 • Sponsor: Fakultas Kedokteran Universitas Indonesia • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Worldwide ICU infection snapshot aims to save lives
Knowledge-focused Not yet recruitingThis observational study will look at 10,000 adults in intensive care units (ICUs) around the world during a single 24-hour period. Researchers want to find out how common infections and antibiotic-resistant bacteria are, how they are treated, and how patients recover. No new tre…
Sponsor: Universidad de la Sabana • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists hunt for clues to Drug-Resistant fungus in Patients' homes and workplaces
Knowledge-focused Not yet recruitingThis study will analyze respiratory samples from 1,000 patients in France to understand why some Aspergillus fungi become resistant to common antifungal drugs. Researchers will test samples for resistance and collect information about patients' environments, jobs, and medication …
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New study to test antifungal drug safety in organ transplant patients
Knowledge-focused Not yet recruitingThis study will observe 120 solid organ transplant recipients who have invasive fungal infections. Researchers will track how well the drug liposomal amphotericin B works and its side effects, compared to historical patients who received other antifungal treatments. The goal is t…
Sponsor: Sichuan Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Tired athletes at risk? new study uses smartphones to analyze landings
Knowledge-focused Not yet recruitingThis study looks at how muscle tiredness changes the way female volleyball players move their legs when landing on one foot. Researchers will use smartphone videos to measure hip, knee, and ankle motion in 35 athletes. The goal is to understand injury risks better, not to test a …
Phase: NA • Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
23,000 seniors join study to unlock secrets of aging and infection
Knowledge-focused Not yet recruitingThis research project aims to understand why older adults get more infections and why those infections can be more serious. By following 23,000 people aged 60 and older, scientists will collect health data and samples like blood and stool to study how the immune system changes wi…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Filipino athlete study aims to unlock secrets of body and metabolism
Knowledge-focused Not yet recruitingThis study looks at how body composition (like fat and muscle) and metabolism (how the body uses energy) are connected in adult and older Filipino athletes. Researchers will measure things like body fat, muscle mass, resting energy use, and fitness levels in 120 athletes and non-…
Sponsor: Food and Nutrition Research Institute, Philippines • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to improve inhaler treatment for lung fungus
Knowledge-focused Not yet recruitingThis study looks at how well an inhaled antifungal drug (liposomal amphotericin B) reaches the lungs in people with chronic pulmonary aspergillosis, a long-term lung infection. About 18 adults will inhale two different doses on separate days and then have special scans to see whe…
Phase: PHASE1 • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Tiny study aims to Fine-Tune fungal drug dosing during plasma exchange
Knowledge-focused Not yet recruitingThis study will look at how the antifungal drug liposomal amphotericin B behaves in 10 critically ill patients with severe fungal infections who are also receiving plasma exchange therapy. The goal is to understand how plasma exchange changes drug levels in the body, which could …
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Tailoring antifungal doses for seniors: a precision approach
Knowledge-focused Not yet recruitingThis study aims to find the best dose of isavuconazole, an antifungal drug, for patients over 60 with invasive fungal infections. Researchers will monitor drug levels in the blood and adjust doses to improve treatment and reduce side effects. The goal is to create personalized do…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Are pro gamers fitter? new study to compare physical fitness of E-Sports athletes
Knowledge-focused Not yet recruitingThis study looks at whether professional e-sports players are more physically fit than amateur players. Researchers will measure reaction time, endurance, and grip strength in 40 adults aged 18 to 30. The goal is to understand how different levels of gaming affect physical health…
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
30,000 blood samples could revolutionize rapid disease testing
Knowledge-focused Not yet recruitingThis study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allo…
Sponsor: LumiraDx UK Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Can the Body's own 'Off Switch' for inflammation predict who survives severe infection?
Knowledge-focused Not yet recruitingThis study will follow 300 adults with severe infections in the ICU to see how levels of specialized pro-resolving mediators (SPMs)—natural molecules that help stop inflammation—change over time. Researchers will use blood samples already collected during routine care, so no extr…
Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Rare fungal infections in grafts under review
Knowledge-focused Not yet recruitingThis study looks back at 300 cases of fungal infections in vascular grafts from 12 French hospitals over 10 years. Researchers want to understand how these infections are treated and what affects patient survival. The goal is to find factors that lead to better outcomes for this …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
ICU fungus study aims to uncover resistance secrets
Knowledge-focused Not yet recruitingThis study will look at Candida fungi from 300 patients in a hematology ICU. Researchers want to see how often these fungi form biofilms (slimy layers that protect them) and whether that makes them resistant to antifungal drugs. The goal is to learn which Candida types are most c…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New study aims to decode dangerous fungal infections in cancer patients
Knowledge-focused Not yet recruitingThis study will collect medical information and samples from 300 cancer patients who have or are at risk for a serious fungal infection called mucormycosis. Researchers hope to learn more about how the infection develops and how to better diagnose and manage it. Participants will…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:07 UTC